ofloxacin has been researched along with carbapenems in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (13.04) | 18.2507 |
| 2000's | 12 (52.17) | 29.6817 |
| 2010's | 7 (30.43) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Akama, M; Araki, H; Iyobe, S; Minami, S; Mitsuhashi, S; Narita, H; Watanabe, Y | 1 |
| Hikida, M; Igarashi, A; Itahashi, K; Kitamura, M; Shiba, T | 1 |
| Arita, K; Daido, K; Kohara, T; Nakamura, K; Ohashi, N; Takeshima, Y | 1 |
| Iwashima, A; Kiguchi, T; Sato, K; Yamaguchi, M | 1 |
| Burgess, DS; Frei, CR; Moczygemba, LR | 1 |
| Hashimoto, H; Horii, T; Maekawa, M; Muramatsu, H; Takeshita, A | 1 |
| Engel, AE; Glass, D; Li, C; Wexler, HM | 1 |
| Chen, WH; Hsueh, PR; Luh, KT | 1 |
| Aksungar, FB; Ozakkaş, F; Topkaya, AE; Tülbek, Y | 1 |
| Miyagi, T; Nakashima, T; Shigehara, K; Shimamura, M | 1 |
| Gutiérrez, F; Hernández, I; Masiá, M; Matoses, C; Murcia, A; Navarro, A; Padilla, S; Romero, I; Sánchez, V | 1 |
| Balbinot, A; Catavitello, C; D'Antonio, D; Favaro, M; Febbo, F; Fontana, C; Savini, V; Talia, M | 1 |
| Naber, KG; Redman, R; Wagenlehner, C; Wagenlehner, FM; Weidner, W | 1 |
| Pezzilli, R | 1 |
| Hedrich, D; Kaniga, K; Kotey, P; Llorens, L; Naber, KG; Redman, R | 1 |
| Damiao, R; Davies, T; Kaniga, K; Kotey, P; Naber, KG; Redman, R | 1 |
| Fukuchi, K; Gomi, K; Takahashi, N; Wakuta, R; Yamaguchi, F | 1 |
| Baba, S; Fujita, T; Iwamura, M; Kimura, M; Kurosaka, S; Matsumoto, K; Minamida, S; Satoh, T; Tabata, K; Tsumura, H | 1 |
| Aydin, S; Ergul, Y; Keleşoğlu, FM; Mete, B; Nazik, H; Öngen, B; Tabak, F; Yemişen, M | 1 |
| Inoue, K; Iwasaki, T; Takaku, K; Yamamoto, T | 1 |
| Kaniga, K; Lee, M; Redman, R; Rice, DA | 1 |
| Davies, TA; He, W; Lynch, AS; Queenan, AM | 1 |
| Alfandari, S; Bajolet, O; Blanchard, H; Colomb-Cotinat, M; Daniau, C; Dumartin, C; Lecuru, M; Simon, L | 1 |
1 review(s) available for ofloxacin and carbapenems
| Article | Year |
|---|---|
A case of Lemierre's syndrome in association with liver abscess without any other metastatic lesions.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Disseminated Intravascular Coagulation; Doripenem; Fusobacterium necrophorum; Humans; Lemierre Syndrome; Liver Abscess; Male; Ofloxacin | 2012 |
5 trial(s) available for ofloxacin and carbapenems
| Article | Year |
|---|---|
Limited efficacy of a nonrestricted intervention on antimicrobial prescription of commonly used antibiotics in the hospital setting: results of a randomized controlled trial.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Counseling; Drug Prescriptions; Drug Utilization; Female; Guideline Adherence; Hospitals; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Organizational Policy; Vancomycin | 2008 |
Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Carbapenems; Doripenem; Double-Blind Method; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies; Pyelonephritis; Urinary Tract Infections | 2009 |
Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Carbapenems; Doripenem; Double-Blind Method; Female; Humans; Infusions, Intravenous; Levofloxacin; Male; Ofloxacin; Pyelonephritis; Urinary Tract Infections | 2009 |
Safety and efficacy of intravenous doripenem for the treatment of complicated urinary tract infections and pyelonephritis.
Topics: Aged; Anti-Infective Agents, Urinary; Carbapenems; Doripenem; Double-Blind Method; Female; Genotype; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Injections, Intravenous; Levofloxacin; Male; Middle Aged; Ofloxacin; Pyelonephritis; Treatment Outcome; Urinary Tract Infections | 2010 |
Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Female; Humans; Imipenem; Intraabdominal Infections; Male; Meropenem; Ofloxacin; Pneumonia; Thienamycins; Treatment Outcome; Urinary Tract Infections | 2013 |
17 other study(ies) available for ofloxacin and carbapenems
| Article | Year |
|---|---|
Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B beta-lactamase.
Topics: Anti-Infective Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporinase; Hydrolysis; Imipenem; Isoelectric Focusing; Microbial Sensitivity Tests; Ofloxacin; Plasmids; Porins; Pseudomonas aeruginosa; Thienamycins | 1996 |
In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Carrier Proteins; Cefdinir; Cephalosporins; Dipeptidases; Drug Stability; Escherichia coli Proteins; Hexosyltransferases; Imipenem; Lactams; Levofloxacin; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Ofloxacin; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Protein Binding; Serine-Type D-Ala-D-Ala Carboxypeptidase; Thienamycins | 1999 |
[Study on antibiotics susceptibility and mechanism of carbapenem-resistance in clinical isolates of Pseudomonas aeruginosa].
Topics: Anti-Infective Agents; beta-Lactam Resistance; Carbapenems; Ceftazidime; Cephalosporins; Imipenem; Meropenem; Ofloxacin; Pseudomonas aeruginosa; Thienamycins | 1999 |
[Isolation-frequency and antibiotic susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Pseudomonas aeruginosa isolated in regional core hospitals in the Nagaoka district of Niigata Prefecture (changes for 3 years)].
Topics: Anti-Infective Agents; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Haemophilus influenzae; Hospitals, Urban; Humans; Japan; Levofloxacin; Ofloxacin; Penicillin G; Pseudomonas aeruginosa; Streptococcus pneumoniae; Time Factors | 2004 |
Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Klebsiella pneumoniae; Lactams; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Ofloxacin; Thienamycins | 2004 |
Characterization of fluoroquinolone and carbapenem susceptibilities in clinical isolates of levofloxacin-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbapenems; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Porins; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |
In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactams; Carbapenems; Doripenem; Ertapenem; Humans; Imipenem; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Thienamycins | 2005 |
Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Length of Stay; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Taiwan | 2005 |
[A case of urinary tract infection caused by Flavimonas oryzihabitans].
Topics: Anti-Infective Agents, Urinary; Bacteriuria; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Middle Aged; Ofloxacin; Pseudomonas; Pseudomonas Infections; Rectal Neoplasms; Renal Insufficiency; Urinary Tract Infections | 2007 |
Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis.
Topics: Aged; Anti-Bacterial Agents; Biopsy, Needle; Blood; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prostate; Prostatitis; Ultrasound, High-Intensity Focused, Transrectal; Urinary Tract Infections; Urine | 2008 |
Bacillus cereus heteroresistance to carbapenems in a cancer patient.
Topics: Adolescent; Anti-Bacterial Agents; Bacillaceae Infections; Bacillus cereus; beta-Lactam Resistance; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Humans; Ofloxacin; Rhabdomyosarcoma | 2009 |
Antibiotic prophylaxis in severe acute pancreatitis: do we need more meta-analytic studies?
Topics: Acute Disease; Antibiotic Prophylaxis; Carbapenems; Cefuroxime; Ciprofloxacin; Humans; Meta-Analysis as Topic; Metronidazole; Ofloxacin; Pancreatitis; Randomized Controlled Trials as Topic | 2009 |
[Validity of using imipenem as a representative carbapenems and levofloxacin as a representative fluoroquinolones in antibiotics susceptibility test for enterobacteriaceae].
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Fluoroquinolones; Imipenem; Levofloxacin; Ofloxacin | 2011 |
Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy, Needle; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Humans; Incidence; Levofloxacin; Male; Middle Aged; Ofloxacin; Prevalence; Prostate; Prostatitis; Rectum | 2011 |
Coexistence of blaOXA-48 and aac(6')-Ib-cr genes in Klebsiella pneumoniae isolates from Istanbul, Turkey.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Transfer Techniques; Genes, Bacterial; Genes, MDR; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Ofloxacin; Plasmids; Turkey | 2011 |
Assessment of the combination of doripenem plus a fluoroquinolone against non-susceptible Acinetobacter baumannii isolates from nosocomial pneumonia patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Carbapenems; Ciprofloxacin; Doripenem; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Female; Levofloxacin; Mice; Ofloxacin; Pneumonia, Ventilator-Associated; Random Allocation; Survival Analysis | 2013 |
Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France.
Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Cross Infection; Delivery of Health Care; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Nitrofurantoin; Ofloxacin; Penicillins; Urinary Tract Infections | 2022 |